KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Non-Current Deffered Revenue: 2017-2019

Historic Non-Current Deffered Revenue for Guardant Health (GH) over the last 1 years, with Sep 2019 value amounting to $10.6 million.

  • Guardant Health's Non-Current Deffered Revenue rose 38.58% to $10.6 million in Q3 2019 from the same period last year, while for Sep 2019 it was $10.6 million, marking a year-over-year increase of 38.58%. This contributed to the annual value of $7.8 million for FY2018, which is 19.99% up from last year.
  • According to the latest figures from Q3 2019, Guardant Health's Non-Current Deffered Revenue is $10.6 million, which was down 3.19% from $10.9 million recorded in Q2 2019.
  • Guardant Health's 5-year Non-Current Deffered Revenue high stood at $10.9 million for Q2 2019, and its period low was $6.5 million during Q4 2017.
  • Over the past 3 years, Guardant Health's median Non-Current Deffered Revenue value was $8.4 million (recorded in 2018), while the average stood at $8.7 million.
  • Data for Guardant Health's Non-Current Deffered Revenue shows a peak YoY skyrocketed of 38.58% (in 2019) over the last 5 years.
  • Over the past 3 years, Guardant Health's Non-Current Deffered Revenue (Quarterly) stood at $6.5 million in 2017, then grew by 19.99% to $7.8 million in 2018, then surged by 38.58% to $10.6 million in 2019.
  • Its last three reported values are $10.6 million in Q3 2019, $10.9 million for Q2 2019, and $9.0 million during Q1 2019.